Type 2 diabetes mellitus in obese
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
7
|
4
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Adenocarcinoma of lung, stage IV
|
disease |
|
Neoplastic Process
|
19
|
6
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Chronic Liver Failure
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
25
|
1
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2017 |
Mucopolysaccharidosis II
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases; Nervous System Diseases
|
Disease or Syndrome
|
26
|
69
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Phobia, Social
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
33
|
8
|
0.020 |
None |
1.000 |
2 |
3
|
2010 |
2012 |
Incontinentia Pigmenti Achromians
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Congenital Abnormality
|
67
|
10
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
End Stage Liver Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
80
|
3
|
0.050 |
None |
1.000 |
5 |
|
2017 |
2019 |
Hepatic Encephalopathy
|
disease |
Digestive System Diseases; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
100
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Acute-On-Chronic Liver Failure
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
140
|
5
|
0.100 |
None |
1.000 |
21 |
|
2016 |
2020 |
Alcohol abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
156
|
24
|
0.320 |
None |
1.000 |
2 |
3
|
2010 |
2012 |
HER2-negative breast cancer
|
disease |
|
Neoplastic Process
|
160
|
18
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Ascites
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
198
|
7
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Alcohol Use Disorder
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
218
|
54
|
0.010 |
None |
1.000 |
1 |
3
|
2012 |
2012 |
HER2-positive carcinoma of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
288
|
26
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Liver Failure
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
293
|
20
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2017 |
Sleep Disorders
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
360
|
38
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Complete atrioventricular block
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
403
|
96
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
6
|
2013 |
2013 |
Waist-Hip Ratio
|
phenotype |
|
Organism Attribute
|
565
|
1138
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Kidney Failure, Acute
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
826
|
32
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Autism Spectrum Disorders
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1071
|
331
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Bipolar Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1183
|
839
|
0.300 |
None |
1.000 |
2 |
|
2008 |
2010 |
Diabetes Mellitus, Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1675
|
954
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2018 |
Hepatitis C
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1768
|
347
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Parkinson Disease
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
2078
|
990
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |